Risk stratification of arrhythmogenic right ventricular cardiomyopathy based on signal averaged electrocardiograms

2014 ◽  
Vol 174 (3) ◽  
pp. 628-633 ◽  
Author(s):  
Ying-Chieh Liao ◽  
Yenn-Jiang Lin ◽  
Fa-Po Chung ◽  
Shih-Lin Chang ◽  
Li-Wei Lo ◽  
...  
2008 ◽  
Vol 50 (4) ◽  
pp. 282-293 ◽  
Author(s):  
Gianfranco Buja ◽  
N.A. Mark Estes ◽  
Thomas Wichter ◽  
Domenico Corrado ◽  
Frank Marcus ◽  
...  

2021 ◽  
Vol 10 (1) ◽  
pp. 26-32
Author(s):  
Ryan Wallace ◽  
Hugh Calkins

Arrhythmogenic right ventricular cardiomyopathy (ARVC), also called arrhythmogenic right ventricular dysplasia or arrhythmogenic cardiomyopathy, is a genetic disease characterised by progressive myocyte loss with replacement by fibrofatty tissue. This structural change leads to the prominent features of ARVC of ventricular arrhythmia and increased risk for sudden cardiac death (SCD). Emphasis should be placed on determining and stratifying the patient’s risk of ventricular arrhythmia and SCD. ICDs should be used to treat the former and prevent the latter, but ICDs are not benign interventions. ICDs come with their own complications in this overall young population of patients. This article reviews the literature regarding the factors that contribute to the assessment of risk stratification in ARVC patients.


2013 ◽  
Vol 24 (4) ◽  
pp. 202-208 ◽  
Author(s):  
M. Silvano ◽  
D. Corrado ◽  
J. Köbe ◽  
G. Mönnig ◽  
C. Basso ◽  
...  

EP Europace ◽  
2017 ◽  
Vol 20 (FI1) ◽  
pp. f20-f29 ◽  
Author(s):  
Chiara Cappelletto ◽  
Davide Stolfo ◽  
Antonio De Luca ◽  
Bruno Pinamonti ◽  
Giulia Barbati ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document